Ovarian epithelial cancer stage IV – Diagnostics – Overview of Information and Clinical Research

Stage IV ovarian epithelial cancer represents the most advanced form of this disease, occurring when cancer cells have traveled beyond the ovaries to distant parts of the body. Understanding the diagnostic process, from initial detection to confirming the extent of spread, can help patients and their families navigate this challenging journey with greater confidence and clarity.

Introduction: When Should You Seek Diagnostic Testing?

Stage IV ovarian epithelial cancer is often discovered when women seek medical attention for persistent symptoms that have worsened over time. Unlike early-stage ovarian cancer, which may cause no noticeable signs, advanced disease typically produces symptoms that become harder to ignore. These symptoms are the body’s way of signaling that something is seriously wrong and medical evaluation is urgently needed.^[1]

You should consider seeking diagnostic testing if you experience symptoms that persist for more than a few weeks and cannot be explained by other common conditions. These warning signs include ongoing abdominal or pelvic pain, persistent bloating that makes your belly area appear larger, feeling full quickly even when you haven’t eaten much, nausea and vomiting, changes in your bowel habits such as constipation or diarrhea, and an urgent need to urinate frequently.^[6] Less common but equally concerning symptoms include unexplained weight loss, extreme tiredness, lower back pain, and abnormal vaginal bleeding.^[7]

Many women initially dismiss these symptoms because they resemble problems caused by digestive issues, bladder infections, or other common ailments. This is precisely why ovarian cancer is often diagnosed at advanced stages. The key difference is that ovarian cancer symptoms don’t go away with typical treatments for these other conditions, and they tend to worsen progressively over time.^[4]

Women over 65 years of age face a higher risk of developing epithelial ovarian cancer, as approximately half of all cases occur in this age group. Those with a family history of ovarian or breast cancer, or who carry genetic mutations in the BRCA1 or BRCA2 genes (genes that normally help prevent cancer but can increase cancer risk when altered), should be especially vigilant about reporting any unusual symptoms to their doctor.^[9]

If you notice any combination of these symptoms lasting for two weeks or longer, or if symptoms are becoming more severe, it’s important to schedule an appointment with your healthcare provider. Early medical consultation doesn’t necessarily mean you have cancer, but it ensures that if cancer is present, it can be identified and addressed as quickly as possible. Remember, these symptoms are your body’s alarm system, and listening to them could make a significant difference in your care journey.

⚠️ Important

Unfortunately, there is currently no effective screening test specifically for ovarian cancer that can reliably detect the disease before symptoms appear. This means most women are diagnosed when the cancer has already reached advanced stages. If you experience persistent symptoms, don’t wait for them to worsen before seeking medical attention, as early evaluation remains your best protection.

Classic Diagnostic Methods for Identifying Stage IV Ovarian Epithelial Cancer

When a doctor suspects ovarian cancer based on your symptoms and medical history, they will begin with a series of tests designed to determine whether cancer is present and, if so, how far it has spread. The diagnostic journey typically involves multiple steps, each providing different pieces of information that together form a complete picture of your condition.

Physical Examination

The first step is usually a pelvic exam, during which your doctor inserts gloved fingers into your vagina while simultaneously pressing down on your abdomen with the other hand. This allows them to feel the size, shape, and consistency of your ovaries and other pelvic organs. During this exam, the doctor also visually examines your external genitalia, vagina, and cervix to look for any abnormalities.^[16]

While a pelvic exam can identify masses or irregularities, it cannot definitively diagnose cancer. Many other conditions can cause similar findings, which is why additional testing is always necessary. The pelvic exam serves as an important starting point that guides doctors toward the next appropriate diagnostic steps.

Blood Tests

Blood tests play a crucial role in the diagnostic process for ovarian cancer. Your doctor will likely order tests to check your overall health and organ function, which helps determine your ability to tolerate various treatments. More specifically, your doctor may test your blood for tumor markers, which are substances often produced by cancer cells.^[16]

The most commonly measured tumor marker for ovarian cancer is called CA-125 (cancer antigen 125), a protein frequently found on the surface of ovarian cancer cells. Elevated CA-125 levels can suggest the presence of ovarian cancer, but it’s important to understand that this test alone cannot confirm a cancer diagnosis. CA-125 levels can also be elevated in women who have other conditions such as endometriosis, pelvic inflammatory disease, or even during menstruation. Conversely, some women with ovarian cancer may have normal CA-125 levels, particularly in early stages or with certain cancer subtypes.^[16]

Blood tests provide valuable clues about your diagnosis and help your doctor understand your overall health status, but they must always be interpreted alongside other diagnostic findings. They cannot tell your doctor with certainty whether you have cancer, but they do contribute important information to the diagnostic puzzle.

Imaging Tests

Imaging tests create detailed pictures of the inside of your body, allowing doctors to see the size, shape, and location of any tumors or abnormalities. Several types of imaging may be used in diagnosing ovarian cancer, each offering different advantages.

Ultrasound imaging uses sound waves to create real-time pictures of your pelvic organs. A transvaginal ultrasound, where a small probe is inserted into the vagina, often provides the clearest images of the ovaries and can help identify suspicious masses. Ultrasound is typically one of the first imaging tests performed because it’s widely available, relatively inexpensive, and doesn’t expose you to radiation.^[16]

CT scans (computed tomography scans) use X-rays taken from multiple angles and computer processing to create detailed, three-dimensional images of your abdomen and pelvis. CT scans are particularly valuable for stage IV disease because they can show whether cancer has spread to the liver, lungs, lymph nodes outside the abdomen, or other distant organs. These scans help doctors map the extent of the disease throughout your body.^[16]

MRI scans (magnetic resonance imaging) use powerful magnets and radio waves instead of radiation to create detailed images of soft tissues. MRI may be used when doctors need more detailed information about specific areas or when CT scans don’t provide sufficient clarity.

Imaging tests are essential for determining whether your cancer is stage IV, which is defined by the presence of cancer in distant organs such as the inside of the liver or spleen, the lungs (either in the tissue itself or as fluid containing cancer cells around the lungs), or lymph nodes outside the abdomen.^[1]

Surgical Diagnosis and Staging

In many cases, doctors cannot confirm a diagnosis of ovarian cancer or determine its exact stage until surgery is performed. During a surgical procedure, the surgeon can directly observe your pelvic and abdominal organs, identify any visible tumors, and remove tissue samples for laboratory analysis.^[16]

During the operation, the surgeon carefully examines the ovaries, fallopian tubes, uterus, and surrounding tissues. They also inspect the peritoneum (the lining of the abdominal cavity), lymph nodes, omentum (a fatty tissue that hangs from the stomach), and other organs where ovarian cancer commonly spreads. The surgeon collects tissue samples from any suspicious areas and may also rinse the abdomen with salt water to collect fluid samples, which are then examined under a microscope for cancer cells. This comprehensive surgical exploration is called surgical staging.^[12]

For stage IV ovarian cancer specifically, surgical findings might reveal cancer in the liver tissue itself, in the spleen, in distant lymph nodes, or in other organs such as the lungs. Alternatively, surgery might reveal a malignant pleural effusion, which means cancer cells are present in fluid that has accumulated around the lungs. These findings confirm that the cancer has spread to distant parts of the body, meeting the criteria for stage IV disease.^[1]

Biopsy and Tissue Analysis

A biopsy involves removing a small sample of tissue so it can be examined under a microscope by a specialist called a pathologist. This is the only way to definitively confirm that cancer is present and to identify what type of cancer you have. Tissue samples may be obtained during surgery, or in some cases, through less invasive procedures such as removing fluid from around the lungs (if a pleural effusion is present).^[16]

The pathologist examines the tissue to determine whether cancer cells are present and identifies the specific subtype of epithelial ovarian cancer. The most common subtype is high-grade serous carcinoma, which accounts for about three out of four epithelial ovarian cancers and is known for spreading quickly. Other subtypes include endometrioid carcinoma, low-grade serous ovarian carcinoma, mucinous carcinoma, and clear cell carcinoma. Each subtype behaves differently and may respond differently to treatments.^[7]

Understanding your specific cancer subtype is important because it helps your healthcare team develop the most appropriate treatment plan for your situation. Different subtypes may require different approaches to achieve the best possible outcomes.

Genetic Testing

Your doctor may recommend genetic testing using a blood sample to look for inherited changes in genes that increase the risk of ovarian cancer. The most well-known of these are mutations in the BRCA1 and BRCA2 genes. Knowing whether you have an inherited genetic change can help your doctor make more informed decisions about your treatment plan, as some therapies work particularly well in cancers associated with these mutations.^[16]

Genetic testing results also have important implications for your family members, such as siblings and children, who may carry the same genetic changes and could benefit from increased screening or preventive measures. Your healthcare team can connect you with a genetic counselor who can help you understand your results and discuss what they mean for you and your family.^[22]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or combinations of treatments to find better ways to fight cancer. Many women with stage IV ovarian epithelial cancer consider participating in clinical trials as part of their treatment plan. However, entering a clinical trial requires meeting specific criteria, which are confirmed through various diagnostic tests.

Standard Qualification Testing

Before you can enroll in a clinical trial, researchers need to confirm certain details about your cancer and your overall health. The diagnostic tests used to qualify you for a trial are similar to those used for initial diagnosis, but they serve the additional purpose of ensuring that you fit the study’s specific requirements.

Imaging tests such as CT scans or MRI scans are typically required to document the size and location of all tumors in your body. These baseline images establish a starting point against which the effectiveness of the experimental treatment can be measured. If the trial is testing a new drug or treatment approach, researchers will compare these initial images with later scans to see whether tumors are shrinking, staying the same, or growing.^[9]

Blood tests are essential for clinical trial enrollment. Beyond checking CA-125 levels, researchers need to verify that your kidneys, liver, and bone marrow are functioning adequately. These organ function tests ensure that you can safely tolerate the treatments being studied. If your organs aren’t working well enough, the experimental treatment could cause serious harm, so trials have minimum function requirements that participants must meet.^[16]

Many clinical trials for ovarian cancer now include genetic testing as a qualification requirement. For example, trials testing treatments specifically designed for cancers with BRCA1 or BRCA2 mutations may only accept participants who have these genetic changes. Conversely, some trials may be designed specifically for patients who do not have these mutations. Confirming your genetic status through blood testing determines which trials you might be eligible for.^[9]

Performance Status Assessment

Clinical trials use standardized scales to assess how well you can perform daily activities, which is called your performance status. This isn’t a single test but rather a clinical evaluation by your doctor. Your performance status helps researchers determine whether you’re strong enough to tolerate the experimental treatment being studied.

Doctors typically assess factors such as whether you can care for yourself, how much time you spend in bed or resting, and whether you can work or do household activities. This assessment provides important information about your overall health and helps ensure that participants in a trial are similar to each other in terms of physical capability, which makes the study results more reliable and easier to interpret.

Biomarker Testing

Some clinical trials require specific biomarker testing beyond standard CA-125 measurements. Biomarkers are biological characteristics that can be measured in blood, tissue, or other body fluids. They might include specific proteins, genes, or other molecules that provide information about your cancer.

For instance, some trials may require testing tumor tissue for specific genetic changes or protein expressions that indicate your cancer might respond to the treatment being studied. This is particularly common for trials testing targeted therapies, which are treatments designed to attack cancer cells with specific molecular characteristics. The tissue used for this testing might come from a previous surgery, or you might need a new biopsy to obtain fresh samples.

Understanding that clinical trial participation requires thorough diagnostic testing helps you prepare for this option. While the testing process may seem extensive, it serves important purposes: protecting your safety, ensuring you receive a treatment appropriate for your specific cancer, and maintaining the scientific integrity of the research that could help future patients.

Prognosis and Survival Rate

Prognosis

The prognosis for stage IV ovarian epithelial cancer depends on multiple factors that are unique to each patient. Among the most significant determinants of survival is the amount of residual disease remaining after surgery. Women who undergo surgery where all visible cancer is successfully removed tend to have better outcomes than those with remaining tumors, regardless of tumor size. This makes the completeness of surgical removal one of the most powerful predictors of how long someone might survive.^[8]

The timing and type of treatment also significantly influence prognosis. Patients who receive upfront surgery (also called primary debulking surgery) followed by chemotherapy may have different outcomes compared to those who receive chemotherapy first to shrink tumors before surgery. Studies have shown that when surgeons can achieve complete tumor removal, the order of treatment matters less than the final surgical result. Additionally, receiving the standard chemotherapy combination of carboplatin and paclitaxel has been associated with improved survival compared to older treatment regimens.^[15]

Your age, overall health, and how well you can perform daily activities all affect your prognosis. Younger women with good general health typically tolerate aggressive treatments better and may have improved survival. The specific subtype of your cancer also matters. High-grade serous carcinoma, while aggressive, often responds well to chemotherapy. Other subtypes like low-grade serous or clear cell carcinomas may respond differently to standard treatments.^[7]

Whether your cancer responds to initial chemotherapy is another crucial factor. Cancers that shrink significantly with first-line treatment tend to have better long-term outcomes. Additionally, women whose cancer has spread to the fluid around the lungs only (stage IVa) generally have a somewhat better prognosis than those with cancer in the liver, spleen, or other distant organs (stage IVb).^[1]

It’s important to remember that prognosis is not destiny. While statistics provide general guidance, every person’s cancer journey is unique. Some women with stage IV disease live many years, especially with modern treatments and ongoing advances in cancer care. Your healthcare team can provide a more personalized estimate based on your specific situation.

Survival Rate

Survival rates for stage IV ovarian epithelial cancer are typically expressed as five-year relative survival rates, which compare the survival of women with this cancer to women in the general population without cancer. These statistics help provide context but should be interpreted carefully, as they represent averages across many different patients and situations.^[6]

For women initially diagnosed with invasive epithelial ovarian cancer at stage IV, the five-year relative survival rate is approximately 31 percent. This means that women with this cancer are about 31 percent as likely to be alive five years after diagnosis as women without this cancer. For other types of stage IV ovarian cancer, the rates differ: germ cell tumors of the ovary have a five-year relative survival rate of about 71 percent, while ovarian stromal tumors have approximately 70 percent.^[6]

These survival statistics are based on women who were diagnosed between 2012 and 2018, which means they reflect treatments available during that time period. Cancer care continues to advance, and newer treatments such as targeted therapies and immunotherapies that have become available more recently may improve outcomes beyond what these historical statistics suggest. As new data becomes available in coming years, these survival rates may change to reflect improved treatment options.

Research has shown that approximately 20 percent of women with late-stage ovarian cancer survive more than 12 years after treatment, and these women are considered cured in medical terms. While this represents a smaller proportion of patients, it demonstrates that long-term survival is possible even with advanced disease.^[20]

Survival rates are influenced by many factors including your age at diagnosis, your overall health, how completely surgeons can remove visible cancer, how well your cancer responds to chemotherapy, and the specific subtype of your cancer. These individual factors mean your personal outlook may be better or worse than the average statistics suggest. Your healthcare team can provide more specific information based on your unique circumstances.^[8]

It’s also worth noting that survival statistics don’t capture quality of life during those years, which is equally important to many patients. Modern treatments increasingly focus not just on extending survival but on maintaining the best possible quality of life during and after treatment. Discussing both survival expectations and quality of life goals with your healthcare team can help guide treatment decisions that align with your personal values and priorities.

#1 Clinical Trials Search in Europe